133 related articles for article (PubMed ID: 14609842)
1. Mycophenolate mofetil inhibits human Tenon fibroblast proliferation by guanosine depletion.
Heinz C; Heise K; Hudde T; Steuhl KP
Br J Ophthalmol; 2003 Nov; 87(11):1397-8. PubMed ID: 14609842
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effect of mycophenolate mofetil on cultured human Tenon fibroblasts.
Heinz C; Hudde T; Heise K; Steuhl KP
Graefes Arch Clin Exp Ophthalmol; 2002 May; 240(5):408-14. PubMed ID: 12073065
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion.
Hauser IA; Renders L; Radeke HH; Sterzel RB; Goppelt-Struebe M
Nephrol Dial Transplant; 1999 Jan; 14(1):58-63. PubMed ID: 10052478
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of mycophenolate mofetil.
Ransom JT
Ther Drug Monit; 1995 Dec; 17(6):681-4. PubMed ID: 8588241
[TBL] [Abstract][Full Text] [Related]
5. Guanosine-5'-triphosphate increases in red blood cells of heart transplant recipients treated with mycophenolate mofetil.
Griesmacher A; Weigel G; Seebacher G; Müller MM
Adv Exp Med Biol; 2000; 486():139-43. PubMed ID: 11783471
[No Abstract] [Full Text] [Related]
6. Mycophenolate mofetil: a unique immunosuppressive agent.
Hood KA; Zarembski DG
Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen.
Ohata K; Espinoza JL; Lu X; Kondo Y; Nakao S
Biol Blood Marrow Transplant; 2011 Feb; 17(2):205-13. PubMed ID: 20736080
[TBL] [Abstract][Full Text] [Related]
9. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM
Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978
[TBL] [Abstract][Full Text] [Related]
10. Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil.
Sanquer S; Breil M; Baron C; Dhamane D; Astier A; Lang P
Clin Pharmacol Ther; 1999 Jun; 65(6):640-8. PubMed ID: 10391669
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
Dayton JS; Turka LA; Thompson CB; Mitchell BS
Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil: a report of the consensus panel.
Shaw LM; Sollinger HW; Halloran P; Morris RE; Yatscoff RW; Ransom J; Tsina I; Keown P; Holt DW; Lieberman R
Ther Drug Monit; 1995 Dec; 17(6):690-9. PubMed ID: 8588243
[No Abstract] [Full Text] [Related]
13. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil.
Allison AC; Eugui EM
Immunol Rev; 1993 Dec; 136():5-28. PubMed ID: 7907572
[No Abstract] [Full Text] [Related]
14. [Mycophenolate mofetil--a new immunosuppressive agent].
Bergan S; Albrechtsen D; Fauchald P
Tidsskr Nor Laegeforen; 1996 Aug; 116(20):2439-41. PubMed ID: 8928103
[TBL] [Abstract][Full Text] [Related]
15. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.
Azzola A; Havryk A; Chhajed P; Hostettler K; Black J; Johnson P; Roth M; Glanville A; Tamm M
Transplantation; 2004 Jan; 77(2):275-80. PubMed ID: 14742993
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells.
Sabuda-Widemann D; Grabensee B; Schwandt C; Blume C
Nephrol Dial Transplant; 2009 Jan; 24(1):52-61. PubMed ID: 18723570
[TBL] [Abstract][Full Text] [Related]
17. Mizoribine and mycophenolate mofetil.
Ishikawa H
Curr Med Chem; 1999 Jul; 6(7):575-97. PubMed ID: 10390602
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells.
Senda M; DeLustro B; Eugui E; Natsumeda Y
Transplantation; 1995 Nov; 60(10):1143-8. PubMed ID: 7482723
[TBL] [Abstract][Full Text] [Related]
19. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
20. Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil.
Schütz E; Shipkova M; Armstrong VW; Wieland E; Oellerich M
Clin Chem; 1999 Mar; 45(3):419-22. PubMed ID: 10053049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
